Last 42,200 KRW
Change Today +1,550 / 3.81%
Volume 417.2K
016100 On Other Exchanges
Symbol
Exchange
KOSDAQ
As of 1:26 AM 03/4/15 All times are local (Market data is delayed by at least 15 minutes).

sansung life & science co lt (016100) Snapshot

Open
40,650
Previous Close
40,650
Day High
42,250
Day Low
40,250
52 Week High
02/25/15 - 43,750
52 Week Low
03/18/14 - 3,580
Market Cap
757.0B
Average Volume 10 Days
366.7K
EPS TTM
-199.00
Shares Outstanding
17.9M
EX-Date
03/23/07
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SANSUNG LIFE & SCIENCE CO LT (016100)

Related News

No related news articles were found.

sansung life & science co lt (016100) Related Businessweek News

No Related Businessweek News Found

sansung life & science co lt (016100) Details

Sansung Life & Science Co., Ltd. manufactures and sells corrugated packaging cardboard boxes in South Korea. It offers double-sided, duplex, and one-sided corrugated cardboards; mask packs, skincare products, mixture, and wrapping materials; and cosmetics. The company was founded in 1986 and is based in Ansan, South Korea.

Founded in 1986

sansung life & science co lt (016100) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

sansung life & science co lt (016100) Key Developments

Sansung Life & Science Co.,Ltd. to Amend Articles of Incorporation

Sansung Life & Science Co.,Ltd. announced that the AGM to be held on Mar. 20, 2015, is to consider and approve amendment of articles of incorporation.

Singapore Medical Group Limited Enters into Joint Venture Agreement with Sansung Life & Science Co., Ltd

The board of directors of Singapore Medical Group Limited referred to the announcement dated 26 November 2014 in relation to the non-binding memorandum of understanding entered into with Sansung Life & Science Co. Ltd. Further to the announcement, the board announced that the company has on 21 January 2015 entered into a joint venture agreement with SLS with the objective to establish a company to engage in the aesthetics business and sales of aesthetic related range of products in the South-East Asia region. Pursuant to the joint venture agreement, a joint venture company, a limited liability company, will be incorporated in the Republic of Singapore with an issued and paid-up capital of USD 1,000,000 consisting of 1 million shares which shall be subscribed, paid up and owned by SMG and SLS. Under the joint venture agreement, the parties agree that: SMG shall in its best effort obtain the licenses, conduct the recruitment of doctors, nurses, and/or paramedic and non-medic staff, procurement of equipment, and other preparation for operational of the JV company. SLS shall provide training and transfer of skills and knowledge to doctors, nurses and medical staff of the JV Company, uses its knowledge and capabilities to research, develop and manufacture new cosmetics products, and grant an exclusive right to the JV company to distribute and sell the new range of products in the South-East Asia region.

Singapore Medical Group Limited Enters into Non-Binding Memorandum of Understanding with Sansung Life & Science Co., Ltd

The board of directors of Singapore Medical Group Limited announced that the company has on November 26, 2014 entered into a non-binding memorandum of understanding with Sansung Life & Science Co. Ltd. (Leaders) in relation to a proposed joint venture. Pursuant to the memorandum of understanding, the company and Leaders have agreed to explore the formation of a joint venture entity in Singapore which will engage in the aesthetics and dermatology businesses and distribution of dermatological and cosmeceutical products in the South- East Asia region. The company and Leaders will hold 51% and 49% equity interest respectively in the Joint Venture Entity. The entry into the memorandum of understanding is not expected to have material effects on the net tangible assets per share and earnings per share of the group for the financial year ending December 31, 2014. The memorandum of understanding is valid for 6 months and is subject to entry into a definitive joint venture agreement by the company and Leaders. Shareholders and potential investors of the company are advised to exercise caution in dealing with the securities of the company as there is no certainty or assurance that as at the date of this announcement the definitive joint venture agreement will be entered into or the Joint Venture will be undertaken at all.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
016100:KS 42,200.00 KRW +1,550

016100 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 016100.
View Industry Companies
 

Industry Analysis

016100

Industry Average

Valuation 016100 Industry Range
Price/Earnings 100.0x
Price/Sales 6.5x
Price/Book 12.1x
Price/Cash Flow 93.2x
TEV/Sales 6.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANSUNG LIFE & SCIENCE CO LT, please visit www.sansung.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.